One particular candidate gene, the dopamine D4 receptor (DRD4), has been the focus of intense study regarding ADHD since the original investigation by La Hoste et al, 1 an observation confirmed by a recent metaanalysis. In an independently recruited sample of 76 families we again observed preferential transmission (TDT 2 = 3.76, P = 0.05, 1 df) of the short repeat alleles from heterozygous parents to the ADHD proband in the Petak Tikvah cohort (Table 1 , new sample). Overall, in the combined Petak Tikvah sample preferential transmission of the short DRD4 repeat was observed (TDT 2 = 9.11, P = 0.0025). Combining all 178 recruited ADHD families (from two geographical locations-Jerusalem and Petak Tikvah), preferential transmission of the short alleles is observed from heterozygote parents to the ADHD proband (TDT 2 = 7.31, P = 0.006). We also analyzed the distribution of the DRD4 exon III polymorphism by case control design comparing 
However, two previous studies from Israel failed to observe this association. 3, 4 We have now recruited an additional sample and, overall, in the combined sample of 178 triads we observe using the transmission disequilibrium test, 5, 6 preferential transmission of the short allele. Additionally, we now report the effect of the DRD4 repeat region on the Test Of Variables of Attention (TOVA), a widely used computerized continuous performance test. 7 Probands with the short exon III repeat performed significantly worse on the TOVA measured both by errors of commission and response time variable. Intriguingly, a 'dose effect' was observed. Increasing repeat size is accompanied by a reduced number of errors of commission and a significant difference is observed between the 2 vs 7 repeats. On the whole, our results lend credence to the notion that the relationship between the DRD4 receptor and ADHD is complex and may be reflecting linkage disequilibrium between the 7 or long DRD4 exon III repeats and a 'true' risk allele in this gene or a neighboring locus. Molecular Psychiatry (2002) 7, 790-794. doi:10.1038/ sj.mp.4001078
In an independently recruited sample of 76 families we again observed preferential transmission (TDT 2 = 3.76, P = 0.05, 1 df) of the short repeat alleles from heterozygous parents to the ADHD proband in the Petak Tikvah cohort (Table 1, new sample) . Overall, in the combined Petak Tikvah sample preferential transmission of the short DRD4 repeat was observed (TDT 2 = 9.11, P = 0.0025). Combining all 178 recruited ADHD families (from two geographical locations-Jerusalem and Petak Tikvah), preferential transmission of the short alleles is observed from heterozygote parents to the ADHD proband (TDT 2 = 7.31, P = 0.006). We also analyzed the distribution of the DRD4 exon III polymorphism by case control design comparing 180 ADHD probands to a large group of control subjects we have genotyped for our studies of normal personality. 8 Similar to the results obtained by family-based design, as shown in Table 2 , there is a small but significant excess of the short DRD4 repeat in the ADHD probands compared to the control subjects (Pearson 2 = 4.57, P = 0.032, 1 df).
We next examined the relationship between DRD4 repeat region and scores on the Test Of Variables of Attention (TOVA), a computerized Continuous Performance Test widely used with ADHD patients. 7 Chil- dren were examined both in the absence (Table 3 ) and the presence of Ritalin or methylphenidate (Table 4) . A significant effect of the long DRD4 repeat was observed on errors of commission (measure of impulsivity) and the response time variable. Children with the long DRD4 repeat did significantly better on these two TOVA paradigms than children with the short allele. There was also a trend (P Ͻ 0.1) for improved performance on errors of omission in those children carrying the long repeat. Most intriguingly, there is a 'dose effect' of DRD4 repeat allele length ( Figure 1 ) and TOVA performance. Increasing repeat size is accompanied by reduced number of errors of commission and a significant difference is observed between the 2 (n = 16) vs 7 (n = 39) repeats (Mann-Whitney test, z = −2.094, P = 0.036).
In the presence of Ritalin, however, there was no effect of the DRD4 gene on any of the TOVA variables (Table 4) .
Paradoxically, the ADHD triads that we are recruiting in Israel show familial transmission from heterozygote parents to probands of the short DRD4 alleles, in contrast to some studies 2 showing that the 7 long repeat confers risk for this disorder. We have now observed this effect in two independently recruited samples and in a combined cohort of 178 triads (115 informative families). Increased frequency of the short DRD4 alleles was also observed when 180 ADHD probands were compared to a large group of 954 control subjects. Additionally, as discussed below, results from grouping scores from ADHD probands on the TOVA further support a deleterious role of the short DRD4 repeat. In the Israeli population the evidence appears convincing that the short DRD4 repeat confers liability for the attention deficit syndrome.
Interestingly, the minority of probands carrying the long DRD4 repeat alleles show significantly better performance on three of the TOVA tasks: errors of commission (a measure of impulsivity), response time variability and errors of omission (a trend). Grouping of TOVA scores by genotype confirms and extends the TDT and association analyses and is consistent with the deleterious role of the short DRD4 repeat and conversely suggests a 'protective' role of the DRD4 long Molecular Psychiatry repeats. Within the ADHD group, carriers of the long DRD4 alleles show better performance on a continuous performance test than ADHD subjects with the short alleles. There is also a significant difference in TOVA scores between carriers of the 2 vs 7 repeat and a trend for an inverse correlation between repeat number and impaired performance. Intriguingly, in the presence of Ritalin the deleterious effects of the short allele on the continuous performance test are no longer observable. These results are consistent with the evidence that the action of this drug is mediated by dopaminergic mechanisms. 9 Changes in dopaminergic tone following Ritalin administration neutralize the differences between carriers of the short vs long DRD4 alleles. In the absence of Ritalin, grouping ADHD children by DRD4 genotype likely groups these children by dopaminergic function that directly moderates performance on the TOVA continuous performance test. Errors of commission (the test subject 'jumps the gun' and prematurely responds to the stimulus) are a measure of impulsivity, a principal diagnostic and clinical attribute of ADHD. It is Figure 1 The effect of DRD4 repeat-size on mean errors of commission (TOVA). Linear test of contrasts across these mean groups (SPSS one-way ANOVA) shows a trend that almost attains significance (F = 3.391, P = 0.067).
interesting to note that the nucleus accumbens, a DArich nucleus in the basal ganglia, has recently been implicated in mediating impulsive behavior in rats. 10 The current investigations raise doubts that there is a direct physiological connection between the DRD4 7 repeat and risk for ADHD. Although the DRD4 repeat polymorphism has been shown to have minor in vitro effects, the actions on cell signaling are weak and of doubtful physiological significance. [11] [12] [13] [14] The most parsimonious explanation that resolves the current findings and some other studies suggesting a weak association between the long allele and ADHD 2 is that the DRD4 exon III polymorphism is in linkage disequilibrium (LD) with the 'true' risk allele.
At least 10 polymorphisms of the DRD4 receptor have been described to date and nine are discussed in a recent review. 15 A likely candidate for a risk allele would appear to be the group of SNPs in the promoter region of the DRD4 receptor, one of which (−521 C/T) is purported in one report to regulate transcription of the receptor. 16, 17 Nevertheless, despite the attractiveness of these promoter region polymorphisms as potential risk alleles, a recent study failed to observe any evidence for linkage between these 5Ј upstream polymorphisms and ADHD. 18 The complex relationship between DRD4 and ADHD may be an example of allelic heterogeneity that can create situations in which multiple different alleles are associated with the disease, rather than a single specific allele. Moreover, some of this allelic heterogeneity may also reflect LD between a marker allele and a 'true' risk allele. Therefore, in some populations the 7-repeat allele (in combination with other allelic variants) would be in LD with ADHD, whereas in other populations the short repeats would be in LD with the disease. Studying haplotypes can to some degree overcome hypothetical weak linkage equilibrium between a particular allele and a true functional polymorphism. 19 As pointed out by Pritchard, 20 it seems likely that the bulk of genetic variance underlying complex diseases is due to loci where susceptibility mutations are mildly deleterious and where there is a high overall mutation rate to the susceptible class. At such loci, the total frequency of susceptibility mutations may be quite high, but there is likely to be extensive allelic heterogeneity at many of these loci. Instead of testing for association at just one or a few SNPs at a time, these might proceed by identifying sets of haplotypes that appear with high frequencies in affected individuals.
Barr et al 21 simultaneously examined three polymorphisms of the D4 receptor gene and observed biased transmission of two haplotypes. Although these findings further support the role of the dopamine D4 gene in ADHD, the authors emphasize that this relationship is not straightforward and the exact mechanism of how DRD4 contributes to the phenotype is unclear. Barr et al note two possibilities that based on current evidence cannot be resolved: (1) that an as-yet-unidentified polymorphism is responsible for the phenotype or the alternative hypothesis; or (2) that the 7-repeat allele in the third exon is directly contributing to the phenotype.
We concur with the Barr et al observation 21 that the evidence is most consistent with the notion that there are more complicated inheritance mechanisms involved in the genetics of the linkage/association findings with DRD4 and ADHD than the simple inheritance of the 7 repeat. Our results, showing that the short DRD4 exon III repeat is preferentially transmitted in our clinical sample of families and that the short alleles have a deleterious effect on performance on a continuous performance test, strongly support this view. Future studies of this locus and ADHD will require larger samples and haplotype analysis to resolve the mechanism by which the DRD4 receptor confers weak risk for this disorder.
Methods and materials
ADHD cases and parents were recruited from the greater Tel-Aviv (Petak Tikvah) and Jerusalem municipal areas. Subjects were all clinical referrals from hospital neurologists, school psychologists and parents.
Families included all diagnosed ADHD children who had two biological parents. The Ethics Committee of the Israeli Health Ministry approved this study and written informed consent was obtained from participating subjects. ADHD criteria followed DSM-IV guidelines that recognize three types of ADHD: ADHD-Predominantly Inattentive (Type I), ADHD-Predominantly Hyperactive Impulsive (Type II), and ADHD-Combined Type (III).
Informants were the parents, the teacher, and the proband. The parents and the proband underwent a thorough, albeit not standardized, clinical interview, which included as a separate item all DSM-IV criteria for ADHD and Conduct Disorder. Two scales, the abbreviated Conners Rating Scales 22 and the Child Behavior Checklist, 23 were also employed. Consensus diagnoses were made according to DSM-IV ADHD or either with or without comorbidity. These DSM-IV diagnoses were based on all available clinical inforMolecular Psychiatry mation and the Child Behaviour Checklist and the Conners Parents and Teachers Rating Scales. When the Conners Teachers Scale was not available, teachers were contacted by telephone and interviewed.
The ADHD subjects were also administered the Test Of Variables of Attention (TOVA), which is a computerized Continuous Performance Test. 7 In the Ritalin phase subjects received 0.3 mg kg −1 of the medication. 3 We excluded cases with a primary diagnosis of Pervasive Developmental Disorder, physical handicap, psychosis, mental retardation, epilepsy, hyperthyroidism, evidence or history of child abuse, or adoption. Children with an IQ less than 80 were excluded. IQ was assessed using the Wechsler Intelligence Scale for Children-Revised. 24 The probands from the Petak Tikvah area consisted of 86% males and 14% females. The average age was 10.68 years ± 3.70 SD. The percentage of probands with ADHD combined type was 68.2%, inattentive 30.6% and 1.2% impulsive. Twenty-seven per cent of the probands had comorbid ODD/CD. The Jerusalem cohort has been previously described. 3 Genotyping DNA was extracted from frozen blood samples using the phenol-chloroform procedure or from fresh blood using a MasterPure kit (Epicentre Technologies, Madison, WI, USA). For some individuals, from whom a blood sample could not be obtained, DNA was obtained from buccal smears, again using the MasterPure kit. The DRD4 exon III repeat region was characterized as previously described. 3, 4 Statistical analysis The transmission disequilibrium test 5, 6 was used to analyze transmission from heterozygote parents to ADHD probands. The Kruskal-Wallis one-way ANOVA is the distribution-free (or nonparametric) analogue of the parametric ANOVA and was used to group TOVA scores by genotype.
The distributions of allele frequencies of the DRD4 repeat polymorphism in the ADHD probands were 2 repeat = 5.6%; 3 = 0.8%; 4 = 76.9%; 5 = 1.1%; 7 = 15.3%; 8 = 0.3%). Using the long vs short scheme or the 7 repeat vs non-7 repeat therefore makes little difference in this cohort, since almost all the 'long' repeats are 7 (there was one proband with an 8 allele).
